Phase I/II Trial of Valproic Acid and Karenitecin for Melanoma

NCT00358319 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

42

Enrollment

OTHER

Sponsor class

Stopped PI left Moffitt

Conditions

Malignant Melanoma

Interventions

DRUG: Karenitecin
DRUG: Valproic Acid

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]